A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer

Gynecologic Oncology

Volumn 115, Issue 3, 2009, Pages 504-509

  Zivanovic, O ^a   Carter, J ^a   Kauff, N D ^a   Barakat, Richard R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Endometrial carcinoma; Fertility preservation; Ovarian cancer; Young women

Indexed keywords

GESTAGEN; MEGESTROL ACETATE;

ADULT; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CASE REPORT; DRUG TREATMENT FAILURE; EMBRYO TRANSFER; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; FEMALE; FEMALE FERTILITY; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LAPAROTOMY; LYMPH NODE DISSECTION; MEDICAL RECORD REVIEW; OOCYTE RETRIEVAL; OVARIAN PRESERVATION; OVARY CANCER; OVULATION INDUCTION; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SALPINGOOOPHORECTOMY; VAGINAL HYSTERECTOMY;

ADULT; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY; HUMANS; OVARIAN NEOPLASMS; RISK FACTORS; YOUNG ADULT;

EID: 70350564290     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.08.011     Document Type: Review

References (21)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 58 2 (2008) 71-96
2. Lee N.K., Cheung M.K., Shin J.Y., et al. Prognostic factors for uterine cancer in reproductive-aged women. Obstet. Gynecol. 109 3 (2007) 655-662
3. Gitsch G., Hanzal E., Jensen D., and Hacker N.F. Endometrial cancer in premenopausal women 45 years and younger. Obstet. Gynecol. 85 4 (1995) 504-508
4. Duska L.R., Garrett A., Rueda B.R., Haas J., Chang Y., and Fuller A.F. Endometrial cancer in women 40 years old or younger. Gynecol. Oncol. 83 2 (2001) 388-393
5. Tran B.N., Connell P.P., Waggoner S., Rotmensch J., and Mundt A.J. Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am. J. Clin. Oncol. 23 5 (2000) 476-480
6. Barakat R.R., Bundy B.N., Spirtos N.M., et al. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study. J. Clin. Oncol. 24 4 (2006) 587-592
7. Lynch H.T., Lynch J.F., Lynch P.M., and Attard T. Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam. Cancer 7 1 (2008) 27-39
8. Ushijima K., Yahata H., Yoshikawa H., et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J. Clin. Oncol. 25 19 (2007) 2798-2803
9. Gotlieb W.H., Beiner M.E., Shalmon B., et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial Cancer. Obstet. Gynecol. 102 4 (2003) 718-725
10. Kim Y.B., Holschneider C.H., Ghosh K., Nieberg R.K., and Montz F.J. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 79 2 (1997) 320-327
11. Ramirez P.T., Frumovitz M., Bodurka D.C., Sun C.C., and Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol. Oncol. 95 1 (2004) 133-138
12. Wright J.D., Buck A.M., Shah M., Burke W.M., Schiff P.B., and Herzog T.J. Safety of ovarian preservation in premenopausal women with endometrial Cancer. J. Clin. Oncol. 27 8 (2009) 1214-1219
13. Lee T.S., Jung J.Y., Kim J.W., Park N.H., Song Y.S., Kang S.B., and Lee H.P. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol. Oncol. 104 1 (2007) 52-57
14. Walsh C., Holschneider C., Hoang Y., Tieu K., Karlan B., and Cass I. Coexisting ovarian malignancy in young women with endometrial Cancer. Obstet. Gynecol. 106 4 (2005) 693-699
15. Shamshirsaz A.A., Withiam-Leitch M., Odunsi K., Baker T., Frederick P.J., and Lele S. Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review. Gynecol. Oncol. 104 3 (2007) 757-760
16. Holinka C.F., Hata H., Kuramoto H., and Gurpide E. Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa). J. Steroid. Biochem. 24 1 (1986) 85-89
17. Smith D.C., Prentice R., Thompson D.J., and Herrmann W.L. Association of exogenous estrogen and endometrial carcinoma. N. Engl. J. Med. 293 23 (1975) 1164-1167
18. Ziel H.K., and Finkle W.D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N. Engl. J. Med. 293 23 (1975) 1167-1170
19. Kauff N.D. How should women with early-onset endometrial cancer be evaluated for lynch syndrome?. J. Clin. Oncol. 25 (2007) 5143-5146
20. Soliman P.T., Broaddus R.R., Schmeler K.M., et al. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?. J. Clin. Oncol. 23 (2005) 9344-9350
21. Trimbos J.B., Vergote I., Bolis G., et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial. J. Natl. Cancer Inst. 95 2 (2003) 113-125